Danel (Adir Yeoshua) Ltd (TASE:DANE) acquired a 21.57% stake in AVIV Scientific LTD. for $22 million on June 23, 2021. The consideration of $22 million is at an enterprise value of $80 million. A provision has been made for a loan convertible into shares in the amount of up to an additional $13 million. The loan will be converted at a price that reflects a 25% discount to the value, which will be determined at the time of conversion. The Chairman of the Danel Group, Rami Antin, is expected to be appointed Chairman of Aviv Scientific. Micky Barnea of Barnea & Co. acted as legal advisor to Danel. Danel (Adir Yeoshua) Ltd (TASE:DANE) completed the acquisition of a 21.57% stake in AVIV Scientific LTD. on June 23, 2021.